scholarly article | Q13442814 |
P50 | author | Lauren A O'Donnell | Q59698464 |
P2093 | author name string | Marc A Dichter | |
David R Lynch | |||
Arpita Agrawal | |||
Kelly L Jordan-Sciutto | |||
Dennis L Kolson | |||
P2860 | cites work | Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults | Q24558984 |
The calpain system | Q28185062 | ||
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. | Q52121112 | ||
Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain | Q71071921 | ||
Properties of inhibitory and excitatory synapses between hippocampal neurons in very low density cultures | Q72486161 | ||
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors | Q73371207 | ||
HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists | Q28334629 | ||
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome | Q28342032 | ||
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
Antagonists selective for NMDA receptors containing the NR2B subunit. | Q33600248 | ||
Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients | Q33785357 | ||
HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. | Q33952997 | ||
Pathways to neuronal injury and apoptosis in HIV-associated dementia. | Q34223078 | ||
NMDA receptor pharmacology: perspectives from molecular biology | Q34367696 | ||
Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes | Q34542359 | ||
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy | Q35098372 | ||
Evidence of apoptotic cell death in HIV encephalitis | Q35795133 | ||
Ca2+-dependent proteases in ischemic neuronal death: a conserved 'calpain-cathepsin cascade' from nematodes to primates | Q35839939 | ||
N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease | Q35999737 | ||
Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures | Q36233456 | ||
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients | Q37400137 | ||
Quinolinic acid production is related to macrophage tropic isolates of HIV-1. | Q38920914 | ||
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. | Q39549145 | ||
Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apopto | Q39684509 | ||
Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. | Q40553022 | ||
Selective activation induced cleavage of the NR2B subunit by calpain. | Q40607831 | ||
Specific proteolysis of the NR2 subunit at multiple sites by calpain | Q40781019 | ||
Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion | Q41618088 | ||
Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. | Q41710744 | ||
Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. | Q42452426 | ||
Regional patterns of brain metabolites in AIDS dementia complex | Q42470182 | ||
Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. | Q42474345 | ||
Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis | Q43436991 | ||
Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. | Q43577438 | ||
Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection | Q43596644 | ||
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages | Q43657062 | ||
Activation of NR1a/NR2B receptors by monocyte-derived macrophage secretory products: implications for human immunodeficiency virus type one-associated dementia | Q44404781 | ||
Direct binding properties of conantokins to native N-methyl-d-aspartate receptors | Q44445169 | ||
CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy. | Q44795363 | ||
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity | Q44895962 | ||
Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss | Q45665036 | ||
Caspase cascades in human immunodeficiency virus-associated neurodegeneration. | Q45732507 | ||
Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. | Q45749830 | ||
The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes | Q45768386 | ||
Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity | Q45773965 | ||
Selective neuronal vulnerability in HIV encephalitis | Q46264554 | ||
Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. | Q48108001 | ||
Neuronal and glial localization of NR1 and NR2A/B subunits of the NMDA receptor in the human cerebral cortex | Q48224791 | ||
Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. | Q48830420 | ||
Development of neuronal sensitivity to toxins in cerebrospinal fluid from HIV-type 1-infected individuals. | Q52064458 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neurotoxicity | Q3338704 |
toxic encephalopathy | Q7830379 | ||
P304 | page(s) | 981-990 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Human immunodeficiency virus (HIV)-induced neurotoxicity: roles for the NMDA receptor subtypes | |
P478 | volume | 26 |
Q37360100 | Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity |
Q42069973 | Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons |
Q37592018 | Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system |
Q34009735 | Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis. |
Q40085897 | Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury. |
Q52720530 | BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism. |
Q33614467 | Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals |
Q35207533 | CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120 |
Q40528935 | CXCL12-induced neurotoxicity critically depends on NMDA receptor-gated and L-type Ca(2+) channels upstream of p38 MAPK. |
Q33387262 | Calpain and proteasomal regulation of antiretroviral zinc finger protein OTK18 in human macrophages: visualization in live cells by intramolecular FRET. |
Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
Q39319848 | Calpain-cleaved type 1 inositol 1,4,5-trisphosphate receptor impairs ER Ca(2+) buffering and causes neurodegeneration in primary cortical neurons |
Q37404160 | Calpain-mediated degradation of MDMx/MDM4 contributes to HIV-induced neuronal damage |
Q24654460 | Cellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegeneration |
Q34466521 | Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection |
Q34508049 | Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection |
Q37239075 | Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity |
Q39943009 | Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity |
Q35927911 | Differential regulation of macrophage phenotype by mature and pro-nerve growth factor |
Q36881509 | Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures |
Q35522971 | Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection |
Q28473257 | Disruption of neuronal autophagy by infected microglia results in neurodegeneration |
Q92707791 | Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca2+/calpain might contribute to postoperative cognitive dysfunction in aging mice |
Q35177482 | E2F1 in neurons is cleaved by calpain in an NMDA receptor-dependent manner in a model of HIV-induced neurotoxicity |
Q33987434 | E2F1 localizes predominantly to neuronal cytoplasm and fails to induce expression of its transcriptional targets in human immunodeficiency virus-induced neuronal damage |
Q28660034 | Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism |
Q58566604 | Enhanced facilitation and diminished inhibition characterizes the pronociceptive endogenous pain modulatory balance of persons living with HIV and chronic pain |
Q37086459 | Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology. |
Q35567289 | Eradication of human immunodeficiency virus from brain reservoirs |
Q36950047 | Genetic knockouts suggest a critical role for HIV co-receptors in models of HIV gp120-induced brain injury |
Q33903612 | Glutamate metabolism and HIV-associated neurocognitive disorders |
Q33882450 | HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment. |
Q40412103 | HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury. |
Q43251339 | HIV-1 clade-specific differences in the induction of neuropathogenesis |
Q48471986 | HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection |
Q36009246 | HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment |
Q34037622 | HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities |
Q37038443 | HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase |
Q36200369 | HIV-infected microglia mediate cathepsin B-induced neurotoxicity. |
Q34311736 | Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders |
Q34139883 | Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders. |
Q38122650 | Human immunodeficiency virus-associated depression: contributions of immuno-inflammatory, monoaminergic, neurodegenerative, and neurotrophic pathways |
Q33582709 | IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury |
Q36086223 | Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy |
Q39692178 | La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic |
Q24318325 | MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease |
Q36950000 | Mitogen-activated protein kinase p38 in HIV infection and associated brain injury |
Q38295226 | NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury |
Q48241774 | NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo |
Q90707715 | Neuroinflammation and EIF2 Signaling Persist despite Antiretroviral Treatment in an hiPSC Tri-culture Model of HIV Infection |
Q37721505 | Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND. |
Q93142905 | Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model |
Q35659668 | Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins. |
Q34970388 | Parallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegeneration |
Q34995472 | Site-specific hyperphosphorylation of pRb in HIV-induced neurotoxicity |
Q34615745 | Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages |
Q90479185 | The Protective Effects and Mechanisms of Apelin/APJ System on Ischemic Stroke: A Promising Therapeutic Target |
Q26752661 | Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein |
Q89493814 | Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells |
Search more.